logo

Last Update

This profile was last updated on 8/6/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Carl Morrison?

Carl D. Morrison

Executive Director of the Center for Personalized Medicine

Roswell Park Cancer Institute

HQ Phone:  (716) 845-2300

Direct Phone: (716) ***-****direct phone

Email: c***@***.org

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Roswell Park Cancer Institute

666 Elm Street

Buffalo, New York,14263

United States

Company Description

About Roswell Park Cancer Institute The mission of Roswell Park Cancer Institute (RPCI) is to understand, prevent and cure cancer. Founded in 1898, RPCI is one of the first cancer centers in the country to be named a National Cancer Institute-designated compre...more

Background Information

Employment History

President, Founder

OmniSeq LLC


President

CSO


Assistant Professor

James Cancer Hospital


Assistant Professor of Pathology

The Ohio State University


Affiliations

Association for Molecular Pathology

Member


College of American Pathologists

Member


New York Genome Center

Board Member


American Society for Investigative Pathology

Member


American College of Pathology

Member


Canadian Academy of Pathology

Member


Education

DVM


Doctorate in Medicine

University of Kentucky


Doctorate in Veterinary Medicine

The Ohio State University College of Veterinary Medicine


MD

Roswell Park Cancer Institute


MD

Wilmot Cancer Institute


Web References(78 Total References)


New Tool for Predicting Treatment Response to Checkpoint Inhibitors | OncoTherapy Network

www.oncotherapynetwork.com [cached]

"While some patients will respond well to checkpoint inhibitors, many will see their tumors progress quickly, so giving them these treatments actually could hurt more than it helps," said Carl Morrison, MD, DVM, who is the Executive Director of the Center for Personalized Medicine at Roswell Park.
We believe our panel of more than 50 markers will be sufficient to predict response in most if not all solid tumors, and are currently expanding the framework to a larger multi-institutional collaboration to confirm these initial findings," Morrison told OncoTherapy Network. Morrison said using this tool it may be possible to improve outcomes and also help eliminate the problem of patients receiving treatments that may offer little or no benefit.


Felicia Lenzo, Author at www.omniseq.com - Page 2 of 2

www.omniseq.com [cached]

Candace Johnson, PhD, Chief Executive Officer of Roswell Park Cancer Institute Carl Morrison, MD, DVM, Executive Director Center for Personalized Medicine, Director Molecular Pathology of Roswell Park Cancer Institute and...


Leadership - www.omniseq.com

www.omniseq.com [cached]

Carl Morrison, MD, DVM
Carl Morrison, MD, DVM President, CSO and Founder Dr. Morrison is OmniSeq's Founder and Chief Scientific Officer. Dr. Morrison is a board-certified pathologist and Executive Director of the Center for Personalized Medicine at Roswell Park Cancer Institute (RPCI) in Buffalo, New York. Dr. Morrison is a Professor and Program Member in Cancer Genetics at RPCI and was recently awarded Roswell Park's prestigious Thomas B. Tomasi Hope Award for his contribution to cancer research. Recognized nationally for his work in translational medicine, Dr. Morrison has authored or co-authored more than 100 peer-reviewed manuscripts with a focus on molecular pathology. His work has been published in many leading journals, including Nature, the Journal of Clinical Oncology, and Cancer Research. Dr. Morrison is a Member of the College of American Pathologists and the Association for Molecular Pathology. Carl Morrison, MD, DVM - President, Chief Scientific Officer, Founder Carl Morrison is a board-certified pathologist, who developed the vision for OmniSeq while leading the Center for Personalized Medicine and Division of Molecular Pathology at RPCI.


Roswell Park Cancer Institute, OmniSeq's Parent Company, Has Announced the Initial Board of Directors for OmniSeq - www.omniseq.com

www.omniseq.com [cached]

Carl Morrison, MD, DVM, Executive Director Center for Personalized Medicine, Director Molecular Pathology of Roswell Park Cancer Institute and President and Chief Scientific Officer of OmniSeq, LLC


About - www.omniseq.com

www.omniseq.com [cached]

Dr. Carl Morrison, Founder of OmniSeq and Executive Director of the Center for Personalized Medicine at Roswell Park Cancer Institute, first envisioned the role of more advanced bioinformatics in clinical decision support while working at Roswell Park.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory